Zynex(ZYXI) Prnewswire·2025-03-28 09:45Core Viewpoint - A class action securities lawsuit has been filed against Zynex, Inc. alleging securities fraud that affected investors between March 13, 2023, and March 11, 2025 [1][2]. Group 1: Allegations of Fraud - The lawsuit claims that Zynex shipped products, including electrodes, in excess of need, leading to inflated revenue [2]. - It is alleged that the company's practice of filing false claims attracted scrutiny from insurers, including the U.S. military health insurance program, Tricare [2]. - The lawsuit suggests that Zynex is likely to face adverse consequences, such as removal from insurer networks and federal penalties, due to these practices [2]. - Defendants' positive statements regarding the company's business and prospects are claimed to be materially misleading and lacking a reasonable basis [2]. Group 2: Legal Process and Participation - Investors who suffered losses in Zynex, Inc. during the specified timeframe have until May 19, 2025, to request to be appointed as lead plaintiff [3]. - Participation in the lawsuit does not require serving as a lead plaintiff, and class members may be entitled to compensation without any out-of-pocket costs [3]. Group 3: Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [4].